Test Background Lamotrigine (brand name Lamicital) is indicated for use singularly and in adjunctive treatment of partial epileptic seizures, as well as primary and secondary tonic-clonic seizures. Also used as a mood stabiliser in bipolar disorders.
Clinical Indications Assessment of patient compliance Assessment of suspected toxicity
Reference Range See report
Sample Required SST (gold top), serum (red top) or saliva (red top)
Sample Volume 1 mL pre-dose trough sample
Turnaround Time Up to 6 weeks
Notes Not currently performed in house; this is a referred test.